Developer of at-home hormone monitoring kits for fertility and perimenopause. These kits measure urinary levels of luteinizing hormone, estrogen metabolites, and progesterone metabolites. Users scan test strips using a mobile application to receive quantitative hormone data. The system provides insights into ovulation patterns and cycle trends to assist with reproductive health management. Results are formatted for sharing with healthcare providers to facilitate clinical discussions. The company was founded in 2017 and headquartered in New York City, United States. It has raised $12.5M in series a funding, with backing from Women Who Tech, Spero Ventures, US Fertility, Virgin, and others. The company operates in the HealthTech - Healthcare Booking Platforms, Retail - Online Mom & Baby Care, High Tech - Wearable Technology space.
Oova
Series ADeveloper of at-home hormone monitoring kits for fertility and perimenopause. These kits measure urinary levels of luteinizing hormone, estrogen metabolites, and progesterone metabolites. Users scan test strips using a mobile application to receive quantitative hormone data. The system provides insights into ovulation patterns and cycle trends to assist with reproductive health management. Results are formatted for…
About
Business model
Wearable Technology > Health and Wellness Devices > Women Health > Fertility Tracking,
Online Mom & Baby Care > Healthcare > Monitoring > Fertility tracking,
Healthcare Booking Platforms > Diagnostics > Internet First Clinical Labs > Biochemical Tests > Fertility
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Backed by funds in our directory
🗂️ Full list of active funds — filter by stage, check size, and geography.